Siesta Medical, Inc.

Siesta Medical, Inc. develops and markets AIRLIFT, a minimally invasive airway treatment device designed as an alternative to CPAP machines and complex sleep apnea surgeries. AIRLIFT is a quick, reversible, and adjustable treatment that can be performed in approximately 30 minutes for obstructive sleep apnea (OSA) patients. The device offers significant advantages over traditional CPAP therapy: no mask, no noise, no machine dependency, and full portability. The procedure provides patient comfort with rapid recovery and is comparable in efficacy to more invasive surgical interventions while reducing treatment costs. AIRLIFT is reimbursed by insurance, indicating FDA clearance and established clinical utility. The company positions the product as a freedom-focused alternative that allows patients to sleep comfortably without continuous positive airway pressure devices, making it suitable for patients who are CPAP-intolerant or seeking definitive treatment rather than long-term device management. The device represents innovation in sleep medicine therapeutics and addresses a substantial market of OSA sufferers seeking effective alternatives to nightly mask-based therapy.